Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10.72x is 46% below its 5-year average of -7.34x, around the middle of its 5-year range (-15.44x–0.01x).
29.33% below its 12-month average of -8.29x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -8.06x.
INTEREST COVERAGE RATIO
-10.72x
INTEREST COVERAGE RATIO AVG TTM
-8.29x
INTEREST COVERAGE RATIO AVG 3Y
-6.30x
INTEREST COVERAGE RATIO AVG 5Y
-7.34x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-29.33%
CURRENT VS 3Y AVG
-70.09%
CURRENT VS 5Y AVG
-45.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-1.05x
median of 232 covered companies
CURRENT VS SECTOR MEDIAN
-920.95%
vs the sector median at left
BridgeBio Pharma, Inc.
Market Cap
$12.95B
Interest Coverage Ratio
-10.72x
TTM Avg
-8.29x
3Y Avg
-6.30x
5Y Avg
-7.34x
Market Cap
$12.89B
Interest Coverage Ratio
5.38x
TTM Avg
5.00x
3Y Avg
4.08x
5Y Avg
8.08x
Market Cap
$13.19B
Interest Coverage Ratio
N/A
TTM Avg
541.83x
3Y Avg
541.83x
5Y Avg
541.83x
Market Cap
$12.52B
Interest Coverage Ratio
-1.06x
TTM Avg
0.71x
3Y Avg
2.65x
5Y Avg
6.89x
Market Cap
$12.49B
Interest Coverage Ratio
144.35x
TTM Avg
102.58x
3Y Avg
62.73x
5Y Avg
62.73x
Market Cap
$12.17B
Interest Coverage Ratio
1.88x
TTM Avg
1.39x
3Y Avg
1.01x
5Y Avg
1.11x
Market Cap
$12.00B
Interest Coverage Ratio
8.55x
TTM Avg
7.42x
3Y Avg
7.61x
5Y Avg
6.89x
Market Cap
$14.16B
Interest Coverage Ratio
-1.69x
TTM Avg
367.76x
3Y Avg
367.76x
5Y Avg
367.76x
Market Cap
$11.47B
Interest Coverage Ratio
3.66x
TTM Avg
4.05x
3Y Avg
3.97x
5Y Avg
4.62x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | -10.72x | -8.29x | -6.30x | -7.34x |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 5.38x | 5.00x | 4.08x | 8.08x |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | N/A | 541.83x | 541.83x | 541.83x |
| Baxter International Inc. (BAX)vs › | $12.52B | -1.06x | 0.71x | 2.65x | 6.89x |
| Penumbra, Inc. (PEN)vs › | $12.49B | 144.35x | 102.58x | 62.73x | 62.73x |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 1.88x | 1.39x | 1.01x | 1.11x |
| Encompass Health Corporation (EHC)vs › | $12.00B | 8.55x | 7.42x | 7.61x | 6.89x |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | -1.69x | 367.76x | 367.76x | 367.76x |
| DaVita Inc. (DVA)vs › | $11.47B | 3.66x | 4.05x | 3.97x | 4.62x |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 46.60x | 29.31x | 24.60x | 23.61x |
Interest Coverage
-10.7x
Debt/Equity
N/A
Current Ratio
1.23
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -8.06x |
| 2026-03-31 | -2.01x |
| 2025-12-31 | -15.44x |
| 2025-09-30 | -12.37x |
| 2025-06-30 | -3.57x |
| 2025-03-31 | -2.48x |
| 2024-12-31 | -7.58x |
| 2024-09-30 | -8.31x |
| 2024-06-30 | -7.65x |
| 2024-03-31 | 0.01x |
| 2023-12-31 | -8.75x |
| 2023-09-30 | -7.77x |
| 2023-06-30 | -7.09x |
| 2023-03-31 | -6.27x |
| 2022-12-31 | -6.46x |
| 2022-09-30 | -6.51x |
| 2022-06-30 | -3.95x |
| 2022-03-31 | -8.54x |
| 2021-12-31 | -10.94x |
| 2021-09-30 | -13.51x |
| 2021-06-30 | -8.67x |
| 2021-03-31 | -17.20x |
| 2020-12-31 | -11.63x |
| 2020-09-30 | -10.97x |
| 2020-06-30 | -11.58x |
| 2020-03-31 | -25.56x |
| 2019-12-31 | -25.87x |
| 2019-09-30 | -25.81x |
| 2019-06-30 | -35.71x |
| 2019-03-31 | -38.15x |
| 2018-12-31 | -55.63x |
| 2018-09-30 | -35.86x |
| 2018-06-30 | -169.67x |
| 2018-03-31 | -5976.86x |
